✦ LIBER ✦

Efficacy of high-dose alkylating chemotherapy in the adjuvant treatment of HER2/neu-negative primary breast cancer: update of the Dutch randomized trial

✍ Scribed by S Rodenhuis, M Bontenbal, LVAM Beex, WM Smit, MA Nooij, EE Voest…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase IB trial of the Her2/neu peptide (

✍ E.A. Mittendorf; S. Khoo; Z.A. Dehqanzada; M.T. Hueman; C.E. Storrer; K.A. Harri 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 88 KB

A Phase II Trial of Split, Low-Dose Doce

✍ Orlando Silva; Gilberto Lopes; Daniel Morgenzstern; Christopher Lobo; Philomena 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 116 KB

The efficacy of bevacizumab plus paclita

✍ Wang, Xuan; Huang, Chun; Li, Man; Gu, Yanjun; Cui, Yanfen; Li, Yan 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 395 KB

The Cost-Utility of Sequential Adjuvant

✍ Chris Skedgel; Daniel Rayson; Tallal Younis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

Evaluation of the prognostic value of HE

✍ Ioannis Kostopoulos; Petroula Arapantoni-Dadioti; Helen Gogas; Savvas Papadopoul 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 406 KB

464 Efficacy and toxicity of docetaxel o

✍ B. Bauer-Kosinska; I. Lemanska; I. Glogowska; R. Sienkiewicz; T. Pienkowski 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB